Self-luminous nanoengineered bacteria with the sustained release of interleukin 2 as an in situ vaccine for enhanced cancer immunotherapy

Journal:
Acta Biomaterialia
Published:
DOI:
10.1016/j.actbio.2025.03.046
Affiliations:
4
Authors:
9
Go to article
Institutions Authors Share
Nanjing Tech University (NanjingTech), China
8.000000
 0.89
Drum Tower Hospital, China
1.000000
 0.11
Interested in Oncology and Carcinogenesis?